Document is current
Any future updates will be listed below
-
Authors
Brandewie, Katie https://orcid.org/0000-0002-1581-5275
Alten, Jeffrey A.
Goldstein, Stuart L.
Rose, James
Kim, Michael E
Ollberding, Nicholas J.
Zang, Huaiyu
Gist, Katja M.
- License Information
-
More Information
Article History
Received: 11 August 2024
Revised: 22 October 2024
Accepted: 28 October 2024
First Online: 18 November 2024
Declarations
:
: CCHMC IRB 2022-0233.
: KMG receives consultant fees from Bioporto Diagnostics and Potrero Medical. KMG did not receive support for this study. SLG receives grant support and consulting fees from Baxter, Mozarc, Bioporto Diagnostics, ExThera Medical, SeaStar Medical, Otsuka, and Talphera. He receives consulting fees from Astra Zeneca, Calcimedica, and Renibus Therapeutics. He is on the Speaker’s Bureau for Baxter and Fresenius Medical. He is Director of Clinical Development for and has equity interest in MediBeacon. There are no further conflicts of interest to report for the remaining authors of this paper.
